DFINE signs exclusive distribution agreement with Biomet for vertebral RF therapy

DFINE Announces Exclusive Distribution Agreement with Biomet (press release)

SAN JOSE, Calif.--(BUSINESS WIRE)--DFINE, Inc., the developer of minimally invasive radiofrequency (RF) targeted therapies for the treatment of vertebral pathologies, today announced it has entered into an exclusive distribution agreement with Biomet, Inc. for its StabiliT® Vertebral Augmentation System in Spain and Portugal. The term of the distribution agreement will be for three years.
“Physicians continue to demand an option that is not only minimally invasive, but that also provides control, safety and predicta...